Stevanato Group SpA
STVN25.355USD
+0.235+0.94%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
6.92BCap. mercado
55.14P/E TTM
Más Datos de Stevanato Group SpA Compañía
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Información de la empresa
Símbolo de cotizaciónSTVN
Nombre de la empresaStevanato Group SpA
Fecha de salida a bolsaJul 16, 2021
Director ejecutivoMr. Franco Stevanato
Número de empleados5521
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 16
DirecciónPiombino Dese (Pd) Via Molinella, 17
CiudadPIOMBINO DESE
Bolsa de valoresNYSE Consolidated
PaísItaly
Código postal35017
Teléfono390499318173
Sitio Webhttps://www.stevanatogroup.com/
Símbolo de cotizaciónSTVN
Fecha de salida a bolsaJul 16, 2021
Director ejecutivoMr. Franco Stevanato
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mauro Stocchi
Mr. Mauro Stocchi
Chief Business Officer
Chief Business Officer
415.36K
+0.60%
,
,
President - Engineering Business Unit
President - Engineering Business Unit
123.81K
+51.51%
Mr. Fabrizio Bonanni
Mr. Fabrizio Bonanni
Independent Director
Independent Director
119.70K
-18.37%
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Independent Director
Independent Director
63.70K
+9.63%
Mr. William J. (Bill) Federici, CPA
Mr. William J. (Bill) Federici, CPA
Independent Director
Independent Director
52.82K
+11.85%
Mr. Riccardo Butta
Mr. Riccardo Butta
President, Americas
President, Americas
30.13K
--
Mr. Alvise Spinazzi
Mr. Alvise Spinazzi
Director
Director
3.30K
--
Carla Costa
Carla Costa
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Franco Moro
Mr. Franco Moro
Director
Director
--
--
Michele Monico
Michele Monico
President - DDS and IVD Business Unit
President - DDS and IVD Business Unit
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mauro Stocchi
Mr. Mauro Stocchi
Chief Business Officer
Chief Business Officer
415.36K
+0.60%
,
,
President - Engineering Business Unit
President - Engineering Business Unit
123.81K
+51.51%
Mr. Fabrizio Bonanni
Mr. Fabrizio Bonanni
Independent Director
Independent Director
119.70K
-18.37%
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Independent Director
Independent Director
63.70K
+9.63%
Mr. William J. (Bill) Federici, CPA
Mr. William J. (Bill) Federici, CPA
Independent Director
Independent Director
52.82K
+11.85%
Mr. Riccardo Butta
Mr. Riccardo Butta
President, Americas
President, Americas
30.13K
--
Desglose de ingresos
Divisa: EURActualizado: dom., 6 de jul
Divisa: EURActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioEUR
Nombre
Ganancia
Proporción
Revenues from other containment and delivery solutions
110.55M
43.08%
Revenues from high-value solutions
110.30M
42.99%
Revenues from engineering
35.75M
13.93%
Por regiónEUR
Nombre
Ganancia
Proporción
EMEA
155.50M
60.60%
North America
75.00M
29.23%
APAC
20.70M
8.07%
South America
5.40M
2.10%
Por negocio
Por región
Por negocioEUR
Nombre
Ganancia
Proporción
Revenues from other containment and delivery solutions
110.55M
43.08%
Revenues from high-value solutions
110.30M
42.99%
Revenues from engineering
35.75M
13.93%
Estadísticas de accionistas
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Conestoga Capital Advisors, LLC
16.38%
Neuberger Berman, LLC
9.27%
T. Rowe Price Investment Management, Inc.
7.55%
TimesSquare Capital Management, LLC
6.77%
Thrivent Asset Management, LLC
5.60%
Other
54.43%
Accionistas
Accionistas
Proporción
Conestoga Capital Advisors, LLC
16.38%
Neuberger Berman, LLC
9.27%
T. Rowe Price Investment Management, Inc.
7.55%
TimesSquare Capital Management, LLC
6.77%
Thrivent Asset Management, LLC
5.60%
Other
54.43%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
55.18%
Investment Advisor
50.76%
Pension Fund
2.88%
Research Firm
2.03%
Individual Investor
1.61%
Hedge Fund
1.08%
Bank and Trust
0.88%
Family Office
0.14%
Holding Company
0.07%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
366
56.87M
114.65%
-13.39M
2025Q1
376
57.92M
116.77%
-13.37M
2024Q4
358
58.53M
118.10%
-12.44M
2024Q3
347
57.73M
116.49%
-11.43M
2024Q2
334
55.33M
111.66%
-5.97M
2024Q1
321
56.90M
119.64%
+12.26M
2023Q4
299
39.58M
111.81%
-6.75M
2023Q3
276
37.46M
106.70%
-5.32M
2023Q2
249
35.30M
102.65%
-7.24M
2023Q1
226
34.68M
101.53%
-8.19M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Conestoga Capital Advisors, LLC
8.19M
16.51%
+106.93K
+1.32%
Mar 31, 2025
Neuberger Berman, LLC
4.60M
9.27%
-37.83K
-0.82%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
3.74M
7.55%
+439.72K
+13.30%
Mar 31, 2025
TimesSquare Capital Management, LLC
3.36M
6.77%
+70.44K
+2.14%
Mar 31, 2025
Thrivent Asset Management, LLC
2.78M
5.6%
-8.29K
-0.30%
Dec 31, 2024
Artisan Partners Limited Partnership
2.28M
4.59%
-77.34K
-3.28%
Mar 31, 2025
Baron Capital Management, Inc.
1.85M
3.73%
+30.34K
+1.67%
Mar 31, 2025
Jackson Square Partners, LLC
1.16M
2.33%
-469.58K
-28.85%
Mar 31, 2025
Thornburg Investment Management, Inc.
1.11M
2.24%
-12.21K
-1.09%
Mar 31, 2025
Lazard Asset Management, L.L.C.
1.09M
2.2%
-61.81K
-5.36%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
First Trust IPOX Europe Equity Opportunities ETF
0.33%
SPDR S&P Kensho New Economies Composite ETF
0.25%
iShares Biotechnology ETF
0.13%
First Trust International Equity Opportunities ETF
0%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
0%
Goldman Sachs Future Health Care Equity ETF
0%
Goldman Sachs MarketBeta International Equity ETF
0%
BNY Mellon International Equity ETF
0%
First Trust IPOX Europe Equity Opportunities ETF
Proporción0.33%
SPDR S&P Kensho New Economies Composite ETF
Proporción0.25%
iShares Biotechnology ETF
Proporción0.13%
First Trust International Equity Opportunities ETF
Proporción0%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
Proporción0%
Goldman Sachs Future Health Care Equity ETF
Proporción0%
Goldman Sachs MarketBeta International Equity ETF
Proporción0%
BNY Mellon International Equity ETF
Proporción0%
Dividendos
Un total de
53.45M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
May 31, 2024
STVN.NB Final Cash Dividend of gross EUR 0.053 paid on Jul 15, 2024 going ex on Jun 04, 2024
Jun 04, 2024
Jul 15, 2024
Jun 04, 2024
Jun 06, 2023
STVN.NB Final Cash Dividend of gross EUR 0.054 paid on Jul 17, 2023 going ex on Jun 07, 2023
Jun 06, 2023
Jul 17, 2023
Jun 07, 2023
Jun 08, 2022
STVN.NB Final Cash Dividend of gross EUR 0.051 paid on Jul 13, 2022 going ex on Jun 13, 2022
Jun 14, 2022
Jul 13, 2022
Jun 13, 2022
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
